Cancer Spike In Men Tied To HPV

Cancer Spike In Men Tied To HPV? Researchers have linked the human papilloma virus to throat cancer in men. The new report, released by Ohio State University, shows the virus is fueling a 28 percent rise in orpharyngeal cases since 1988, an additional 10,000 cases per year.

The researchers report that if the cancer spike trend continues it will surpass cervical as the nation’s main HPV-related disease within 10 years.

The finding that it can spread to the throat and cause cancer in men with HPV may increase pressure on Merck andamp; Co., the second-largest U.S. drugmaker, to conduct large-scale trials to see if its vaccine Gardasil, which prevents throat infections in men with HPV, said Maura Gillison, an oncologist at Ohio State University and study senior author.

Researchers believe that HPV is going to shift from women to men in this decade because of the increasing number of sexual partners and its exposure.

“There is an urgency to try to figure out how to prevent this,” said Dr. Amy Chen of the American Cancer Society.

Younger men with HPV can get vaccinated to prevent genital warts and anal cancer, and additional problems caused by human papillomavirus. However, protection against the oral virus hasn’t been studied in either gender, said report author Dr. Maura Gillison, a head-and-neck cancer specialist at Ohio State.

Regardless, the report suggests that patients with virus-linked oral tumors have better survival odds than those with other types of this disease, possibly because they tend to be younger.